Journal
EXPERIMENTAL DERMATOLOGY
Volume 31, Issue 4, Pages 528-534Publisher
WILEY
DOI: 10.1111/exd.14495
Keywords
autoimmune bullous diseases; epidermolysis bullosa acquisita; extracellular Hsp70; heat shock proteins; reactive oxygen species
Categories
Funding
- Polish National Science Centre [2017/25/B/NZ6/00305, 2020/39/B/NZ6/00357]
- Cluster of Excellence Precision Medicine in Chronic Inflammation [EXC 2167]
Ask authors/readers for more resources
The study revealed the previously unknown role of extracellular Hsp70 in epidermolysis bullosa acquisita (EBA) and suggested it as a potential treatment target. Experimental findings indicated that Hsp70 may exacerbate the clinical severity of EBA by promoting inflammatory responses and oxidative stress.
Heat shock protein 90 (Hsp90) and Hsp70 are chaperones implicated in different inflammatory disorders, given their property to impact innate and adaptive immune responses. Here, we determined the so far unknown role of extracellular Hsp70 in epidermolysis bullosa acquisita (EBA), an anti-type VII collagen autoantibody-mediated blistering dermatosis. The in vivo pathophysiological relevance of extracellular Hsp70 was demonstrated in an anti-type VII collagen antibody transfer-induced EBA mouse model in which elevated blood levels of this chaperone were recorded. We found that Hsp70-treated mice had a more intense clinical disease severity compared to controls that were paralleled by increased levels of cutaneous matrix metalloproteinase 9 and plasma hydrogen peroxide. The latter finding was confirmed in an independent reactive oxygen species release assay using EBA-specific immune complexes combined with recombinant Hsp70. Finally, cell culture experiments using human naive peripheral blood mononuclear cells (PBMC) revealed that extracellular Hsp70 stimulated the secretion of the T cell-derived pro-inflammatory cytokines IL-6 and IL-8. This work extends knowledge about the role of Hsps in autoimmune bullous diseases, suggesting that extracellular Hsp70 represents a pathophysiological factor and potential treatment target in EBA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available